36507-30-9NC(=O)N1c2ccccc2C2OC2c2ccccc21ZRWWEEVEIOGMMT-UHFFFAOYSA-NCarbamazepine-10,11-epoxide is an epoxide and metabolite of carbamazepine. It has a role as a drug metabolite, an allergen and a marine xenobiotic metabolite. It is an epoxide, a dibenzoazepine and a member of ureas. It is functionally related to a carbamazepine.
36507-30-9Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
H411 (90.5%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]
P273, P391, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 42 reports by companies from 5 notifications to the ECHA C&L Inventory.
UsesA metabolite of Carbamazepine (C175840). Representative lots contained 1-2% carbamazepine by HPLC.
UsesA metabolite of Carbamazepine (C175840).Representative lots contained 1-2% carbamazepine by HPLC.
UsesA metabolite of Carbamazepine. Representative lots contained 1-2% carbamazepine by HPLC
General DescriptionCarbamazepine-10,11-epoxide is the primary, active metabolite in both urine and serum of carbamazepine, an anticonvulsant drug used in the treatment of epilepsy and bipolar disorder as well as trigeminal neuralgia. Potential toxicity of the epoxide metabolite requires regular therapeutic drug monitoring by LC or LC/MS for patients taking carbamazepine.
No reaction records under the current filter.
Loading…
DTXSID60891456CHEMBL1258CHEBI:3388DefinitionChEBI: An epoxide and metabolite of carbamazepine.